PET-CT 在原发性骨与软组织肿瘤诊治中的价值:单中心255例中国患者经验
该单中心回顾性研究纳入255例原发性骨与软组织肿瘤患者,评估PET-CT基于SUVmax的诊断与分期价值。结果显示,SUVmax诊断原发性恶性骨肉瘤的敏感度为96.6%,软组织肉瘤为91.2%;高级别骨肉瘤SUVmax显著高于低级别骨肉瘤,而高、低级别软组织肉瘤间无显著差异;骨肉瘤化疗后SUVmax显著下降与良好预后相关。结论认为PET-CT可作为组织病理学检查的有价值补充方法。
要点
- SUVmax诊断原发性恶性骨肉瘤敏感度96.6%,软组织肉瘤91.2%。
- 高分级骨肉瘤SUVmax(平均8.4±5.5)显著高于低分级(平均3.9±1.8)。
- 骨肉瘤化疗后SUVmax显著下降提示预后良好。
核心结论
- 基于SUVmax的PET-CT应用可作为组织病理学检查的有价值补充方法,用于原发性骨与软组织肉瘤的诊断和分期。
研究设计与样本
- 单中心回顾性研究,纳入2006年1月至2015年7月该科255例原发性骨与软组织肿瘤患者,回顾PET-CT结果与组织病理学报告,记录并分析各类型肉瘤的SUVmax。
诊断标准与关键数值
- 基于SUVmax诊断原发性恶性骨肉瘤的敏感度为96.6%,诊断软组织肉瘤的敏感度为91.2%。
- 高分级骨肉瘤SUVmax平均8.4±5.5,低分级骨肉瘤平均3.9±1.8,差异显著(p<0.001)。
- 高分级软组织肉瘤SUVmax平均7.5±5.1,低分级软组织肉瘤平均5.3±3.7,差异无统计学意义(p=0.229)。
临床应用与阅片要点
- SUVmax对原发性骨与软组织肉瘤诊断敏感度高,可作为组织病理学检查的补充用于诊断和分期。
- 骨肉瘤化疗后SUVmax显著下降与良好预后相关,可辅助疗效评估。
局限性
- 单中心回顾性研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The current study was carried out to assess the value of positron emission tomography (PET)/CT on the diagnosis and staging of primary musculoskeletal tumors.
METHODS: PET-CT test results and histopathological study reports of all the patients with primary musculoskeletal tumors in our department from January 2006 to July 2015 were retrospectively reviewed. Maximum standardized uptake value (SUVmax) in these PET-CT reports were recorded and analyzed respectively for each type of sarcoma.
RESULTS: A total of 255 patients were included in the final analysis. Sensitivity of SUVmax based diagnosis was 96.6% for primary malignant osseous sarcomas and 91.2% for soft tissue sarcomas. SUVmax of high-grade osseous sarcomas (average 8.4 ± 5.5) was significantly higher (p < 0.001) than low-grade osseous sarcomas (average 3.9 ± 1.8); based on current case series, SUVmax of high-grade soft tissue sarcomas (7.5 ± 5.1) was not significantly different (p = 0.229) from that of low-grade soft tissue sarcomas (5.3 ± 3.7). Significant decrease of SUVmax value after chemotherapy was associated with favorable prognosis in patients with osteosarcoma.
CONCLUSION: Results of the current study indicate that, the SUVmax based application of PET-CT can be a valuable supplementary method to histopathological tests regarding the diagnosis and staging of primary musculoskeletal sarcomas.
ADVANCES IN KNOWLEDGE: SUVmax based application of PET-CT is a highly sensitive method in diagnosis of primary osseous and soft tissue sarcomas in Chinese patients.
引用
- Muheremu A, Wen T, Niu X, et al. PET-CT for the diagnosis and treatment of primary musculoskeletal tumors in Chinese patients - experience from 255 patients in a single center. Br J Radiol. 2021. PMID: 34591688. doi:10.1259/bjr.20210785
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。